Acylin Therapeutics Receives $2,000,000 Series A Financing

  • Feed Type
  • Date
    6/4/2012
  • Company Name
    Acylin Therapeutics
  • Mailing Address
    1616 Eastlake Ave Seattle, WA 98102
  • Company Description
    The company develops cancer, metabolic and disease therapies.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.